Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | -- | -- | -- | 0.00 | 0.00 |
| Gross Profit | -- | -- | -- | 0.00 | 0.00 |
| Selling General And Administration | 34,892 | 59,609 | 64,605 | 37,017 | 96,958 |
| General And Administrative Expense | 34,592 | 59,609 | 54,001 | 34,996 | 96,270 |
| Other Operating Expenses | 44,146 | 84,032 | 62,862 | 35,691 | 609,033 |
| Operating Expense | 79,038 | 143,641 | 127,467 | 72,708 | 705,991 |
| Operating Income | -79,038 | -143,641 | -127,467 | -72,708 | -705,991 |
| EBIT | -79,038 | -143,641 | -127,467 | -62,593 | -705,991 |
| Interest Expense | -- | -- | -- | 0.00 | 0.00 |
| Interest Expense Non Operating | -- | -- | -- | 0.00 | 0.00 |
| Net Interest Income | -- | -- | -- | 0.00 | 0.00 |
| Other Income Expense | 3,058 | -276,020 | 36,441 | 10,115 | 269,841 |
| Other Non Operating Income Expenses | 4,133 | 12,175 | 36,711 | 11,196 | 270,528 |
| Special Income Charges | 0.00 | -288,194 | -- | 0.00 | 0.00 |
| Gain On Sale Of Security | -1,075 | -1.00 | -270.00 | -1,081 | -687.00 |
| Pretax Income | -75,980 | -419,661 | -91,026 | -62,593 | -436,150 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -75,980 | -419,661 | -91,026 | -62,593 | -436,150 |
| Net Income From Continuing Operation Net Minority Interest | -75,980 | -419,661 | -91,026 | -62,593 | -436,150 |
| Net Income Including Noncontrolling Interests | -75,980 | -419,661 | -91,026 | -62,593 | -436,150 |
| Net Income Common Stockholders | -75,980 | -419,661 | -91,026 | -62,593 | -436,150 |
| Net Income | -75,980 | -419,661 | -91,026 | -62,593 | -436,150 |
| EBITDA | -79,038 | -143,641 | -127,467 | -62,593 | -705,991 |
| Normalized EBITDA | -77,963 | 144,554 | -127,197 | -61,512 | -705,304 |
| Reconciled Depreciation | -- | -- | -- | 0.00 | 0.00 |
| Basic EPS | 0.00 | -0.01 | 0.00 | -- | -0.01 |
| Diluted EPS | 0.00 | -0.01 | 0.00 | -- | -0.01 |
| Basic Average Shares | 68.0M | 68.0M | 68.0M | -- | 65.5M |
| Diluted Average Shares | 68.0M | 68.0M | 68.0M | -- | 65.5M |
| Total Unusual Items | -1,075 | -288,195 | -270.00 | -1,081 | -687.00 |
| Total Unusual Items Excluding Goodwill | -1,075 | -288,195 | -270.00 | -1,081 | -687.00 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -74,905 | -131,466 | -90,756 | -61,512 | -435,463 |
| Diluted NI Availto Com Stockholders | -75,980 | -419,661 | -91,026 | -62,593 | -436,150 |
| Gain On Sale Of Ppe | -- | -- | -- | 0.00 | 0.00 |
| Impairment Of Capital Assets | 0.00 | 288,194 | -- | 0.00 | 0.00 |
| Net Income Continuous Operations | -75,980 | -419,661 | -91,026 | -62,593 | -436,150 |
| Net Non Operating Interest Income Expense | -- | -- | -- | 0.00 | 0.00 |
| Other Gand A | 34,592 | 59,609 | 54,001 | 34,996 | 96,270 |
| Reconciled Cost Of Revenue | -- | -- | -- | 0.00 | 0.00 |
| Selling And Marketing Expense | 300.00 | 0.00 | 10,604 | 2,021 | 688.00 |
| Total Expenses | 79,038 | 143,641 | 127,467 | 72,708 | 705,991 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 70.00 | 56,789 | 180,006 | 287,969 | 434,442 |
| Cash Cash Equivalents And Short Term Investments | 70.00 | 56,789 | 180,006 | 287,969 | 434,442 |
| Cash Financial | 70.00 | 56,789 | 180,006 | 287,969 | 434,442 |
| Receivables | 1,945 | 4,871 | 19,737 | 69,190 | 29,118 |
| Prepaid Assets | 9,294 | 11,267 | 19,736 | 0.00 | 14,333 |
| Current Assets | 11,309 | 72,927 | 219,479 | 357,159 | 477,893 |
| Net PPE | 0.00 | 0.00 | 288,194 | 288,194 | 288,194 |
| Total Non Current Assets | 0.00 | 0.00 | 288,194 | 288,194 | 288,194 |
| Total Assets | 11,309 | 72,927 | 507,673 | 645,353 | 766,087 |
| Payables And Accrued Expenses | 56,776 | 38,281 | 41,191 | 51,134 | 98,079 |
| Other Current Liabilities | -- | 4,133 | 16,308 | 53,019 | 64,215 |
| Current Liabilities | 56,776 | 42,414 | 57,499 | 104,153 | 162,294 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 56,776 | 42,414 | 57,499 | 104,153 | 162,294 |
| Common Stock | 11.7M | 11.7M | 11.7M | 11.7M | 11.7M |
| Capital Stock | 11.7M | 11.7M | 11.7M | 11.7M | 11.7M |
| Additional Paid In Capital | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M |
| Retained Earnings | -13.7M | -13.6M | -13.2M | -13.1M | -13.1M |
| Common Stock Equity | -45,467 | 30,513 | 450,174 | 541,200 | 603,793 |
| Stockholders Equity | -45,467 | 30,513 | 450,174 | 541,200 | 603,793 |
| Total Equity Gross Minority Interest | -45,467 | 30,513 | 450,174 | 541,200 | 603,793 |
| Total Capitalization | -45,467 | 30,513 | 450,174 | 541,200 | 603,793 |
| Net Tangible Assets | -45,467 | 30,513 | 450,174 | 541,200 | 603,793 |
| Tangible Book Value | -45,467 | 30,513 | 450,174 | 541,200 | 603,793 |
| Working Capital | -45,467 | 30,513 | 161,980 | 253,006 | 315,599 |
| Invested Capital | -45,467 | 30,513 | 450,174 | 541,200 | 603,793 |
| Share Issued | 68.0M | 68.0M | 68.0M | 68.0M | 68.0M |
| Ordinary Shares Number | 68.0M | 68.0M | 68.0M | 68.0M | 68.0M |
| Taxes Receivable | 1,945 | 4,871 | 19,737 | 69,190 | 29,118 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -56,719 | -123,217 | -107,963 | -146,473 | -697,486 |
| Cash Flow From Continuing Operating Activities | -56,719 | -123,217 | -107,963 | -146,473 | -697,486 |
| Depreciation And Amortization | -- | -- | -- | 0.00 | 0.00 |
| Depreciation Amortization Depletion | -- | -- | -- | 0.00 | 0.00 |
| Change In Working Capital | 23,394 | 20,425 | 19,774 | -72,684 | 9,439 |
| Change In Receivables | 2,926 | 14,866 | 49,453 | -40,072 | -13,628 |
| Change In Payables And Accrued Expense | 18,495 | -2,910 | -9,943 | -46,945 | 16,735 |
| Other Non Cash Items | -4,133 | -12,175 | -36,711 | -11,196 | -270,528 |
| Capital Expenditure | -- | -- | -- | -- | -25,000 |
| Purchase Of PPE | 0.00 | -- | -- | 0.00 | -25,000 |
| Net PPE Purchase And Sale | 0.00 | -- | -- | 0.00 | -25,000 |
| Investing Cash Flow | 0.00 | -- | -- | 0.00 | -25,000 |
| Cash Flow From Continuing Investing Activities | 0.00 | -- | -- | 0.00 | -25,000 |
| Repayment Of Debt | -- | -- | -- | 0.00 | 0.00 |
| Net Issuance Payments Of Debt | -- | -- | -- | 0.00 | 0.00 |
| Issuance Of Capital Stock | 0.00 | -- | -- | 0.00 | 125,000 |
| Net Common Stock Issuance | 0.00 | -- | -- | 0.00 | 125,000 |
| Financing Cash Flow | 0.00 | -- | -- | 0.00 | 98,198 |
| Cash Flow From Continuing Financing Activities | 0.00 | -- | -- | 0.00 | 98,198 |
| Changes In Cash | -56,719 | -123,217 | -107,963 | -146,473 | -624,288 |
| Beginning Cash Position | 56,789 | 180,006 | 287,969 | 434,442 | 1.1M |
| End Cash Position | 70.00 | 56,789 | 180,006 | 287,969 | 434,442 |
| Free Cash Flow | -56,719 | -123,217 | -107,963 | -146,473 | -722,486 |
| Interest Paid Supplemental Data | -- | -- | 0.00 | 0.00 | 0.00 |
| Asset Impairment Charge | 0.00 | -- | -- | 0.00 | -247.00 |
| Change In Prepaid Assets | 1,973 | 8,469 | -19,736 | 14,333 | 6,332 |
| Common Stock Issuance | 0.00 | -- | -- | 0.00 | 125,000 |
| Depreciation | -- | -- | -- | 0.00 | 0.00 |
| Gain Loss On Sale Of PPE | -- | -- | -- | 0.00 | 0.00 |
| Long Term Debt Payments | -- | -- | -- | 0.00 | 0.00 |
| Net Income From Continuing Operations | -75,980 | -419,661 | -91,026 | -62,593 | -436,150 |
| Net Long Term Debt Issuance | -- | -- | -- | 0.00 | 0.00 |
| Net Other Financing Charges | -- | -- | -- | 0.00 | -26,802 |
| Sale Of PPE | -- | -- | -- | 0.00 | 0.00 |